A U.S. study found that women with BRCA1 gene mutations have broken and unrepaired PTEN genes -- a finding that could help explain why these women are at a higher risk of breast cancer. Drugmakers have seen positive results from trials of experimental drugs that target tumors by breaking the chemical cascade associated with broken PTEN genes, a researcher said.

Full Story:
USA Today

Related Summaries